These findings align with the lower prevalence of risk-associated polymorphisms in total responders, specifically in genes linked to obesity (FTO), liver injury (PNPLA3), and cardiometabolic risk (TRIB1AL), as shown in Supplementary Figure S5. Here, TRIB1AL is linked to Obesity.